First-in-man histotripsy of hepatic tumors: the THERESA trial, a feasibility study
J Vidal-Jove, X Serres, E Vlaisavljevich… - International Journal …, 2022 - Taylor & Francis
Rationale Current hepatic locoregional therapies are limited in terms of effectiveness and
toxicities. Given promising pre-clinical results, a first in-human trial was designed to assess …
toxicities. Given promising pre-clinical results, a first in-human trial was designed to assess …
The role of interventional radiology for the treatment of hepatic metastases from neuroendocrine tumor: an updated review
M Barat, AS Cottereau, A Kedra, S Dermine… - Journal of clinical …, 2020 - mdpi.com
Interventional radiology plays an important role in the management of patients with
neuroendocrine tumor liver metastasis (NELM). Transarterial embolization (TAE) …
neuroendocrine tumor liver metastasis (NELM). Transarterial embolization (TAE) …
Predicting treatment response to intra-arterial therapies for hepatocellular carcinoma with the use of supervised machine learning—an artificial intelligence concept
Purpose To use magnetic resonance (MR) imaging and clinical patient data to create an
artificial intelligence (AI) framework for the prediction of therapeutic outcomes of transarterial …
artificial intelligence (AI) framework for the prediction of therapeutic outcomes of transarterial …
Liver transarterial embolizations in metastatic neuroendocrine tumors
L de Mestier, M Zappa, O Hentic, V Vilgrain… - Reviews in Endocrine …, 2017 - Springer
The management of patients with well-differentiated neuroendocrine tumors (NET) and non-
resectable liver metastases is challenging. Liver-directed transarterial embolization (TAE) …
resectable liver metastases is challenging. Liver-directed transarterial embolization (TAE) …
Optimization of the BCLC staging system for locoregional therapy for hepatocellular carcinoma by using quantitative tumor burden imaging biomarkers at MRI
Background Patients with intermediate-and advanced-stage hepatocellular carcinoma
(HCC) represent a highly heterogeneous patient collective with substantial differences in …
(HCC) represent a highly heterogeneous patient collective with substantial differences in …
The relevance of CT-based geometric and radiomics analysis of whole liver tumor burden to predict survival of patients with metastatic colorectal cancer
A Muehlberg, JW Holch, V Heinemann, T Huber… - European …, 2021 - Springer
Objectives To investigate the prediction of 1-year survival (1-YS) in patients with metastatic
colorectal cancer with use of a systematic comparative analysis of quantitative imaging …
colorectal cancer with use of a systematic comparative analysis of quantitative imaging …
The combination of hepatobiliary phase with Gd-EOB-DTPA and DWI is highly accurate for the detection and characterization of liver metastases from neuroendocrine …
R Hayoz, N Vietti-Violi, R Duran, JF Knebel… - European …, 2020 - Springer
Objectives To compare the diagnostic accuracy of dynamic contrast-enhanced phases,
hepatobiliary phase (HBP), and diffusion-weighted imaging (DWI) for the detection of liver …
hepatobiliary phase (HBP), and diffusion-weighted imaging (DWI) for the detection of liver …
Long term efficacy and assessment of tumor response of transarterial chemoembolization in neuroendocrine liver metastases: a 15-year monocentric experience
C Touloupas, M Faron, J Hadoux, F Deschamps… - Cancers, 2021 - mdpi.com
Simple Summary Neuroendocrine tumors (NET) are rare tumors, with long-term survival
even for patients with liver metastases. Transarterial chemoembolization (TACE) is one of …
even for patients with liver metastases. Transarterial chemoembolization (TACE) is one of …
Lipiodol deposition and washout in primary and metastatic liver tumors after chemoembolization
N Nezami, JMM Van Breugel, M Konstantinidis… - in vivo, 2021 - iv.iiarjournals.org
Background/Aim: Lipiodol is the key component of conventional trans-arterial
chemoembolization. Our aim was to evaluate lipiodol deposition and washout rate after …
chemoembolization. Our aim was to evaluate lipiodol deposition and washout rate after …
Early whole-body diffusion-weighted MRI helps predict long-term outcome following peptide receptor radionuclide therapy for metastatic neuroendocrine tumors
V Vandecaveye, RC Dresen, E Pauwels… - Radiology: Imaging …, 2022 - pubs.rsna.org
Purpose To evaluate the predictive value of 7-week apparent diffusion coefficient change
from baseline (ADCratio7w) at whole-body diffusion-weighted MRI (WB-DWI MRI) after one …
from baseline (ADCratio7w) at whole-body diffusion-weighted MRI (WB-DWI MRI) after one …